---
layout: project
title: "Medicare Prescriber Analysis: Identifying Opioid Abuse Patterns"
excerpt: "Led analysis of Medicare prescription data to identify patterns of opioid abuse using ensemble machine learning methods."
tags: [Python, Machine Learning, Healthcare, Ethics]
thumbnail: opioid-analysis.png
featured: true
github: https://github.com/naalu/opioid-analysis
---

## Problem

The opioid epidemic has caused tremendous harm, but identifying problematic prescribing patterns in massive healthcare datasets is challenging. Medicare Part D data contains millions of records, requiring sophisticated analytical approaches to separate signal from noise.

## Approach

Using publicly available Medicare prescriber data, I developed a comprehensive analysis pipeline to identify high-risk prescription patterns:

1. **Data Engineering**: Processed millions of prescription records, handling missing data, outliers, and data quality issues
2. **Feature Engineering**: Created meaningful predictive features from raw prescription counts, specialties, and geographic patterns
3. **Model Development**: Built ensemble models (Random Forest, Gradient Boosting) to classify prescribing risk levels
4. **Ethical Framework**: Developed guidelines for responsible implementation of predictive algorithms in healthcare settings

## Tools

- **Python** (pandas, NumPy, scikit-learn)
- **Ensemble Methods** (Random Forest, XGBoost)
- **Data Visualization** (matplotlib, seaborn)
- **Jupyter Notebooks** for reproducible analysis

## Impact

- Successfully identified **prescription abuse patterns** that correlate with known problematic prescribers
- Developed an **ethical AI framework** for responsible deployment of healthcare algorithms
- Model could support targeted intervention programs for opioid reduction efforts

<div class="highlight-box">
  <strong>Key Takeaway:</strong> Healthcare ML isn't just about model accuracy—it requires understanding the human stakes and building ethical safeguards into the system design from the start.
</div>

## Methodology Deep Dive

The analysis used a multi-stage approach:

$$\text{Risk Score} = \sum_{i=1}^{n} w_i \cdot f_i(x)$$

Where $f_i$ represents different risk factors (prescribing volume, drug mix, geographic clustering) and $w_i$ are learned weights from the ensemble model.

Feature importance analysis revealed that prescription volume alone was insufficient—the **combination** of high volume, specific drug combinations, and geographic isolation patterns provided the strongest signal.
